Results 11 to 20 of about 1,580,164 (331)

A Review on Lactoferrin and Central Nervous System Diseases

Cells, 2021
Central nervous system (CNS) diseases are currently one of the major health issues around the world. Most CNS disorders are characterized by high oxidative stress levels and intense inflammatory responses in affected tissues.
Yu-Qi Li, Chuang Guo
doaj   +2 more sources

Central nervous system manifestations in rheumatic diseases [PDF]

Journal of Medical Biochemistry, 2011
Neurological involvement is associated with significant morbidity in patients with rheumatic diseases, and may indicate heightened disease activity. Connective tissue diseases result from immunologic or autoimmune reactions.
Cojocaru Mihaela Inimioara, Cojocaru Manole, Silosi Isabela, Vrabie Doina Camelia   +3 more
doaj   +2 more sources

Oral microbiota and central nervous system diseases: A review [PDF]

Neuroprotection
Oral microbiota is the second largest microbial colony in the body and forms a complex ecological community that influences oral and brain health. Impaired homeostasis of the oral microbiota can lead to pathological changes, resulting in central nervous ...
Xiaoxuan Zhang, Mengmeng Zhong, Yang Li, Hui Wang, Guangjun Xi, Feng Wang, Chao Cheng, Yachen Shi   +7 more
doaj   +2 more sources

Neurosurgical gene therapy for central nervous system diseases [PDF]

Neurotherapeutics
Viral vector mediated gene therapies for neurodegenerative and neurodevelopmental conditions that require neurosurgical administration continue to expand.
Ruchit V. Patel, Pranav Nanda, R. Mark Richardson   +2 more
doaj   +2 more sources

Mitochondrion-based organellar therapies for central nervous system diseases [PDF]

Cell Communication and Signaling
As most traditional drugs used to treat central nervous system (CNS) diseases have a single therapeutic target, many of them cannot treat complex diseases or diseases whose mechanism is unknown and cannot effectively reverse the root changes underlying ...
Mengke Zhao, Jiayi Wang, Shuaiyu Zhu, Meina Wang, Chong Chen, Liang Wang, Jing Liu   +6 more
doaj   +2 more sources

TREK-1 in central nervous system diseases [PDF]

Chinese Medical Journal
Man Chen, Yile Wang, Zhen Xiong, Yongkang Fang, Zhou Zhu, Ting Gao   +5 more
doaj   +2 more sources

Piezo1: the key regulators in central nervous system diseases [PDF]

Frontiers in Cellular Neuroscience
The occurrence and development of central nervous system (CNS) diseases is a multi-factor and multi-gene pathological process, and their diagnosis and treatment have always posed a serious challenge in the medical field. Therefore, exploring the relevant
Yi Xu, Yuheng Wang, Yanling Yang, Xiaowei Fang, Lidong Wu, Jialing Hu, Jin Li, Shuchong Mei   +7 more
doaj   +2 more sources

Extracellular particles: emerging insights into central nervous system diseases [PDF]

Journal of Nanobiotechnology
Extracellular particles (EPs), including extracellular vesicles (EVs) and non-vesicular extracellular particles (NVEPs), are multimolecular biomaterials released by cells that play a crucial role in intercellular communication.
Shenyuan Chen, Qinghua Bao, Wenrong Xu, Xiao Zhai   +3 more
doaj   +2 more sources

Central nervous system Whipple's disease [PDF]

Annals of Neurology, 1997
Contains fulltext : 25412___.PDF (Publisher’s version ) (Open Access)
Verhagen, W.I.M., Huygen, P.L.M., Dalman, J.E.   +2 more
openaire   +4 more sources

Brainstem syndrome at onset is related to an early MS diagnosis in Peru: A national referral center cohort

Heliyon, 2021
Background: MS is unpredictable regarding clinical symptoms; however, certain symptoms represent the preferred localization of white matter lesions such as brainstem, spinal cord; or optic nerve.
César Caparó-Zamalloa, Sheila Castro-Suarez, Jaqueline Cortez-Escalante, Wilfor Aguirre-Quispe, Erik Guevara-Silva, Victor Osorio-Marcatinco, María Meza-Vega   +6 more
doaj   +1 more source